FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

PG Warmerdam

Research Profile

Procedures

Disorders

Activities & Behaviors

Geographic Areas

Concepts & Ideas

Living Beings

Papillomaviridae

Co-author Network

Publications

TOP 3
Rob Boer; Harry J de Koning; Gerrit J van Oortmarssen; PG Warmerdam; Paul J van der Maas
Stage distribution at first and repeat examinations in breast cancer screening.
Rob Boer; Harry J de Koning; A Threlfall; PG Warmerdam; Andrew Street; E Friedman; Ciaran B J Woodman
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
PM Beemsterboer; PG Warmerdam; Rob Boer; Harry J de Koning
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of PG Warmerdam (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: Rob Boer; Harry J de Koning; Gerrit J van Oortmarssen; PG Warmerdam; Paul J van der Maas
Stage distribution at first and repeat examinations in breast cancer screening.
Journal of medical screening 1999;6(3):132-8.
1998: Rob Boer; Harry J de Koning; A Threlfall; PG Warmerdam; Andrew Street; E Friedman; Ciaran B J Woodman
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
BMJ (Clinical research ed.) 1998;317(7155):376-9.
1998: PM Beemsterboer; PG Warmerdam; Rob Boer; Harry J de Koning
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?
Journal of medical screening 1998;5(2):81-7.
1997: Rob Boer; Harry J de Koning; PM Beemsterboer; PG Warmerdam; F H Schroeder
A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer.
The Journal of urology 1997;157(5):1768-71; discussion 1771-2.
1997: PG Warmerdam; Harry J de Koning; Rob Boer; PM Beemsterboer; ML Dierks; Enno Swart; Bernt-Peter Robra
Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
Journal of epidemiology and community health 1997;51(2):180-6.
1997: Marjolein van Ballegooijen; Elske van den Akker; PG Warmerdam; C J Meijer; J M Walboomers; J Dik F Habbema
Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.
British journal of cancer 1997;76(5):651-7.
1995: Harry J de Koning; Rob Boer; PG Warmerdam; PM Beemsterboer; Paul J van der Maas
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
Journal of the National Cancer Institute 1995;87(16):1217-23.
1994: PM Beemsterboer; Harry J de Koning; PG Warmerdam; Rob Boer; Enno Swart; M L Dierks; Bernt-Peter Robra
Prediction of the effects and costs of breast-cancer screening in Germany.
International journal of cancer. Journal international du cancer 1994;58(5):623-8.
1994: Rob Boer; PG Warmerdam; Harry J de Koning; G van Oortmarssen
Extra incidence caused by mammographic screening.
Lancet 1994;343(8903):979.
1988: M van Duin; J van den Tol; PG Warmerdam; H Odijk; Dies Meijer; A Westerveld; Dirk Bootsma; Jan H J Hoeijmakers
Evolution and mutagenesis of the mammalian excision repair gene ERCC-1.
Nucleic acids research 1988;16(12):5305-22.